Calcium-binding protein S100P and cancer: Mechanisms and clinical relevance

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 1, 2012, Pages 1-9

  Jiang, Hongfei ^a   Hu, Hang ^a   Tong, Xiaomei ^a   Jiang, Qiuhong ^a   Zhu, Haiyan ^a   Zhang, Songying ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Carcinogenesis; S100P; Tumor diagnosis

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCIUM BINDING PROTEIN; CALCIUM ION; CALCYCLIN; CATHEPSIN D; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EZRIN; KRUPPEL LIKE FACTOR; PROTEIN S100P; SMAD PROTEIN; STAT PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; BILE DUCT CARCINOMA; BINDING SITE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER PROGNOSIS; CANCER SCREENING; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CHROMOSOMAL LOCALIZATION; COLON CANCER; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; GENE EXPRESSION REGULATION; GENE STRUCTURE; HUMAN; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PURIFICATION; RECEIVER OPERATING CHARACTERISTIC; REVIEW; S100P GENE; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION INITIATION; TUMOR CELL LINE; TUMOR GENE; TUMOR GROWTH;

ANIMALS; CALCIUM-BINDING PROTEINS; HUMANS; NEOPLASM PROTEINS; NEOPLASMS;

EID: 84863116714     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1062-5     Document Type: Review

References (80)

1. Arumugam T, Simeone DM, Schmidt AM, Logsdon CD (2004) S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 279: 5059-5065 (Pubitemid 38220521)
2. 2+-regulated ezrin-S100P interaction and its role in tumor cell migration. J Biol Chem 283: 29331-29340
3. Averboukh L, Liang P, Kantoff PW, Pardee AB (1996) Regulation of S100P expression by androgen. Prostate 29: 350-355 (Pubitemid 27014349)
4. Bartling B, Rehbein G, Schmitt WD, Hofmann HS, Silber RE, Simm A (2007) S100A2-S100P expression profile and diagnosis of nonsmall cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy. Eur J Cancer 43: 1935-1943 (Pubitemid 47284868)
5. Basu GD, Azorsa DO, Kiefer JA, Rojas AM, Tuzmen S, Barrett MT, Trent JM, Kallioniemi O, Mousses S (2008) Functional evidence implicating S100P in prostate cancer progression. Int J Cancer 123: 330-339 (Pubitemid 351842017)
6. 2+ binding properties. Eur J Biochem 207: 541-547
7. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG et al (2002) Geneexpression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8: 816-824
8. Bertram J, Palfner K, Hiddemann W, Kneba M (1998) Elevated expression of S100P, CAPL and MAGE 3 in doxorubicinresistant cell lines: comparison of mRNA differential display reverse transcription-polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression. Anticancer Drugs 9: 311-317 (Pubitemid 28241820)
9. Black AR, Black JD, Azizkhan-Clifford J (2001) Sp1 and kruppellike factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188: 143-160 (Pubitemid 32622905)
10. Briozzo P, Morisset M, Capony F, Rougeot C, Rochefort H (1988) In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res 48: 3688-3692
11. Bucciarelli LG, Wendt T, Rong L, Lalla E, Hofmann MA, Goova MT, Taguchi A, Yan SF, Yan SD, Stern DM, Schmidt AM (2002) RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol Life Sci 59: 1117-1128
12. Bulk E, Hascher A, Liersch R, Mesters RM, Diederichs S, Sargin B, Gerke V, Hotfilder M, Vormoor J, Berdel WE et al (2008) Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice. Cancer Res 68: 1896-1904 (Pubitemid 351416576)
13. Cagdas DN, Parlar AI, Pac A, Tutun U, Balci S (2008) A Turkish family with Ellis-van Creveld syndrome in six siblings; linkage analysis on 4p16 region (D4S3360-D4S2366). Genet Couns 19: 387-395
14. Cancemi P, Di Cara G, Albanese NN, Costantini F, Marabeti MR, Musso R, Lupo C, Roz E, Pucci-Minafra I (2010) Large-scale proteomic identification of S100 proteins in breast cancer tissues. BMC Cancer 10: 476
15. Cerami A, Vlassara H, Brownlee M (1988) Role of advanced glycosylation products in complications of diabetes. Diabetes Care 11: 73-79 (Pubitemid 19005580)
16. Chazin WJ (1995) Releasing the calcium trigger. Nat Struct Biol 2: 707-710
17. Deng H, Shi J, Wilkerson M, Meschter S, Dupree W, Lin F (2008) Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens. Am J Clin Pathol 129: 81-88 (Pubitemid 352038597)
18. Diederichs S, Bulk E, Steffen B, Ji P, Tickenbrock L, Lang K, Zanker KS, Metzger R, Schneider PM, Gerke V et al (2004) S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res 64: 5564-5569 (Pubitemid 39095550)
19. Donato R (2011) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637-668
20. Dowen SE, Crnogorac-Jurcevic T, Gangeswaran R, Hansen M, Eloranta JJ, Bhakta V, Brentnall TA, Luttges J, Kloppel G, Lemoine NR (2005) Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am J Pathol 166: 81-92 (Pubitemid 40051662)
21. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee K (2004) S100 proteins in the epidermis. J Invest Dermatol 123: 23-33 (Pubitemid 38833459)
22. Emoto Y, Kobayashi R, Akatsuka H, Hidaka H (1992) Purification and characterization of a new member of the S-100 protein family from human placenta. Biochem Biophys Res Commun 182: 1246-1253
23. Filipek A (2006) S100A6 and CacyBP/SIP-two proteins discovered in Ehrlich ascites tumor cells that are potentially involved in the degradation of beta-catenin. Chemotherapy 52: 32-34 (Pubitemid 43004435)
24. Filipek A, Jastrzebska B, Nowotny M, Kuznicki J (2002) CacyBP/ SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family. J Biol Chem 277: 28848-28852
25. Fuchs SY, Ougolkov AV, Spiegelman VS, Minamoto T (2005) Oncogenic beta-catenin signaling networks in colorectal cancer. Cell Cycle 4: 1522-1539
26. Fuentes MK, Nigavekar SS, Arumugam T, Logsdon CD, Schmidt AM, Park JC, Huang EH (2007) RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum 50: 1230-1240 (Pubitemid 47087458)
27. Gao JH, He ZJ, Wang Q, Li X, Li YX, Liu M, Zheng JH, Tang H (2008) Low expression of S100P associated with paclitaxel resistance in ovarian cancer cell line. Chin Med J (Engl) 121: 1563-1568
28. Gibadulinova A, Oveckova I, Parkkila S, Pastorekova S, Pastorek J (2008) Key promoter elements involved in transcriptional activation of the cancer-related gene coding for S100P calcium-binding protein. Oncol Rep 20: 391-396
29. Gibadulinova A, Tothova V, Pastorek J, Pastorekova S (2010) Transcriptional regulation and functional implication of S100P in cancer. Amino Acids [Epub ahead of print]
30. 2+-switch model. J Mol Biol 283: 679-694 (Pubitemid 28486730)
31. Gribenko A, Lopez MM, Richardson JM 3rd, Makhatadze GI (1998) Cloning, overexpression, purification, and spectroscopic characterization of human S100P. Protein Sci 7: 211-215 (Pubitemid 28133763)
32. Guerreiro Da Silva ID, Hu YF, Russo IH, Ao X, Salicioni AM, Yang X, Russo J (2000) S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. Int J Oncol 16: 231-240
33. Györffy B et al (2006) Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer 118(7): 1699-1712 (Pubitemid 43376433)
34. Hamada S, Satoh K, Hirota M, Kanno A, Ishida K, Umino J, Ito H, Kikuta K, Kume K, Masamune A et al (2011) Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma. Cancer Sci 102: 150-156
35. Heizmann CW, Ackermann GE, Galichet A (2007) Pathologies involving the S100 proteins and RAGE. Subcell Biochem 45: 93-138
36. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P et al (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901 (Pubitemid 29375048)
37. Hsieh HL, Schafer BW, Sasaki N, Heizmann CW (2003) Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem Biophys Res Commun 307: 375-381 (Pubitemid 36818881)
38. Hsieh HL, Schafer BW, Weigle B, Heizmann CW (2004) S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells. Biochem Biophys Res Commun 316: 949-959 (Pubitemid 38368045)
39. Ingersoll RG, Hetmanski J, Park JW, Fallin MD, McIntosh I, Wu-Chou YH, Chen PK, Yeow V, Chong SS, Cheah F et al (2010) Association between genes on chromosome 4p16 and non-syndromic oral clefts in four populations. Eur J Hum Genet 18: 726-732
40. Jiang F, Shults K, Flye L, Hashimoto Y, Van Der Meer R, Xie J, Kravtsov V, Price J, Head DR, Briggs RC (2005) S100P is selectively upregulated in tumor cell lines challenged with DNA cross-linking agents. Leuk Res 29: 1181-1190 (Pubitemid 41169235)
41. 2+- dependent binding and activation of dormant ezrin by dimeric S100P. Mol Biol Cell 14: 2372-2384 (Pubitemid 36724327)
42. Kretsinger RH (1976) Calcium-binding proteins. Annu Rev Biochem 45: 239-266
43. Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D, Park NH, Wong DT (2004) Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10: 8442-8450 (Pubitemid 40053408)
44. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE, Kuick R, Hanash S (2003) Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63: 2649-2657 (Pubitemid 36605209)
45. Mandinova A, Atar D, Schafer BW, Spiess M, Aebi U, Heizmann CW (1998) Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J Cell Sci 111(Pt 14): 2043-2054 (Pubitemid 28391069)
46. Massague J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19: 2783-2810 (Pubitemid 41739965)
47. Matsuzawa SI, Reed JC (2001) Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 7: 915-926 (Pubitemid 32525739)
48. McNutt NS (1998) The S100 family of multipurpose calcium-binding proteins. J Cutan Pathol 25: 521-529 (Pubitemid 28552506)
49. Mousses S, Wagner U, Chen Y, Kim JW, Bubendorf L, Bittner M, Pretlow T, Elkahloun AG, Trepel JB, Kallioniemi OP (2001) Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling. Oncogene 20: 6718-6723 (Pubitemid 33020600)
50. Mousses S, Bubendorf L, Wagner U, Hostetter G, Kononen J, Cornelison R, Goldberger N, Elkahloun AG, Willi N, Koivisto P et al (2002) Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res 62: 1256-1260 (Pubitemid 34407773)
51. Namba T, Homan T, Nishimura T, Mima S, Hoshino T, Mizushima T (2009) Up-regulation of S100P expression by non-steroidal anti-inflammatory drugs and its role in anti-tumorigenic effects. J Biol Chem 284: 4158-4167
52. Norremolle A, Budtz-Jorgensen E, Fenger K, Nielsen JE, Sorensen SA, Hasholt L (2009) 4p16.3 haplotype modifying age at onset of Huntington disease. Clin Genet 75: 244-250
53. Ohuchida K, Mizumoto K, Egami T, Yamaguchi H, Fujii K, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M (2006) S100P is an early developmental marker of pancreatic carcinogenesis. Clin Cancer Res 12: 5411-5416 (Pubitemid 44497255)
54. Parkkila S, Pan PW, Ward A, Gibadulinova A, Oveckova I, Pastorekova S, Pastorek J, Martinez AR, Helin HO, Isola J (2008) The calcium-binding protein S100P in normal and malignant human tissues. BMC Clin Pathol 8: 2
55. Peifer M, Polakis P (2000) Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 287: 1606-1609 (Pubitemid 30127755)
56. Polymeropoulos MH, Ide SE, Wright M, Goodship J, Weissenbach J, Pyeritz RE, Da Silva EO, Ortiz De Luna RI, Francomano CA (1996) The gene for the Ellis-van Creveld syndrome is located on chromosome 4p16. Genomics 35: 1-5 (Pubitemid 26236144)
57. Quesnelle KM, Boehm AL, Grandis JR (2007) STAT-mediated EGFR signaling in cancer. J Cell Biochem 102: 311-319 (Pubitemid 47519405)
58. Raelson JV, Little RD, Ruether A, Fournier H, Paquin B, Van Eerdewegh P, Bradley WE, Croteau P, Nguyen-Huu Q, Segal J et al (2007) Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci. Proc Natl Acad Sci USA 104: 14747-14752 (Pubitemid 350003214)
59. Ross S, Cheung E, Petrakis TG, Howell M, Kraus WL, Hill CS (2006) Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription. EMBO J 25: 4490-4502 (Pubitemid 44498123)
60. Salama I, Malone PS, Mihaimeed F, Jones JL (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34: 357-364 (Pubitemid 351381290)
61. Sato N, Hitomi J (2002) S100P expression in human esophageal epithelial cells: human esophageal epithelial cells sequentially produce different S100 proteins in the process of differentiation. Anat Rec 267: 60-69 (Pubitemid 34465299)
62. Schafer BW, Heizmann CW (1996) The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 21: 134-140
63. Schafer BW, Wicki R, Engelkamp D, Mattei MG, Heizmann CW (1995) Isolation if a yac clone covering a cluster of 9 S100 genes on human-chromosome-1q21- rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 25: 638-643
64. Schmierer B, Hill CS (2007) TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8: 970-982 (Pubitemid 350174642)
65. Shiota M, Tsunoda T, Song Y, Yokomizo A, Tada Y, Oda Y, Naito S (2010) Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin. BJU Int
66. Shyu RY, Huang SL, Jiang SY (2003) Retinoic acid increases expression of the calcium-binding protein S100P in human gastric cancer cells. J Biomed Sci 10: 313-319
67. Singh RK, Indra D, Mitra S, Mondal RK, Basu PS, Roy A, Roychowdhury S, Panda CK (2007) Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene. Hum Genet 122: 71-81 (Pubitemid 47040575)
68. Siu YT, Jin DY (2007) CREB-a real culprit in oncogenesis. FEBS J 274: 3224-3232
69. Stern DM, Yan SD, Yan SF, Schmidt AM (2002) Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res Rev 1: 1-15 (Pubitemid 38340348)
70. Streicher WW, Lopez MM, Makhatadze GI (2010) Modulation of quaternary structure of S100 proteins by calcium ions. Biophys Chem 151: 181-186
71. Surowiak P, Maciejczyk A, Materna V, Drag-Zalesinska M, Wojnar A, Pudelko M, Kedzia W, Spaczynski M, Dietel M, Zabel M, Lage H (2007) Unfavourable prognostic significance of S100P expression in ovarian cancers. Histopathology 51: 125-128 (Pubitemid 46976362)
72. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C et al (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405: 354-360 (Pubitemid 30337069)
73. Tutar Y (2006) Dimerization and ion binding properties of S100P protein. Protein Pept Lett 13: 301-306
74. Wang G, Platt-Higgins A, Carroll J, de Silva Rudland S, Winstanley J, Barraclough R, Rudland PS (2006) Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res 66: 1199-1207 (Pubitemid 43165991)
75. Wang Q, He Z, Gao J, Hu S, Huang M, Liu M, Zheng J, Tang H (2008) S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro. Cancer Lett 272: 277-284
76. Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, Crnogorac-Jurcevic T (2007) The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res 67: 8633-8642 (Pubitemid 47437439)
77. Yao R, Davidson DD, Lopez-Beltran A, MacLennan GT, Montironi R, Cheng L (2007) The S100 proteins for screening and prognostic grading of bladder cancer. Histol Histopathol 22: 1025-1032 (Pubitemid 47034168)
78. Yoo HJ, Yun BR, Kwon JH, Ahn HS, Seol MA, Lee MJ, Yu GR, Yu HC, Hong B, Choi K, Kim DG (2009) Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells. Exp Mol Med 41: 102-115
79. Zenteno JC, Ruiz G, Perez-Cano HJ, Camargo M (2008) Familial Wolfram syndrome due to compound heterozygosity for two novel WFS1 mutations. Mol Vis 14: 1353-1357
80. Zollino M, Murdolo M, Neri G (2008) The terminal 760 kb region on 4p16 is unlikely to be the critical interval for growth delay in Wolf-Hirschhorn syndrome. J Med Genet 45: 544